---
nav_exclude: true
layout: single
title: "Early Estimates of Updated 2023-2024 (Monovalent XBB.1.5) COVID-19 Vaccine Effectiveness Against Symptomatic SARS-CoV-2 Infection Attributable to Co-Circulating Omicron Variants Among Immunocompetent Adults - Increasing Community Access to Testing Program, United States, September 2023-January 2024"
source_url: "https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=742448"
source_layer: us_cdc_mmwr
category: surveillance_summary
date: 2024-02-01
confidence: 中
mmwr_volume: ""
mmwr_issue: ""
---

## 摘要

This report describes vaccine effectiveness for the updated COVID-19 vaccine in preventing symptomatic SARS-CoV-2 infection.

## 詳細內容

This report describes vaccine effectiveness for the updated COVID-19 vaccine in preventing symptomatic SARS-CoV-2 infection.

## 關鍵發現

(需要透過 WebFetch 補充或人工審核來提取關鍵發現)

---
*萃取時間: 2026-02-05T15:10:14Z*
*資料來源: CDC MMWR*
